GenesisCare & Vision RT Announce Expansion of Global Strategic Partnership

GenesisCare, one of the largest providers of integrated cancer care globally, and Vision RT, the inventor of and a market leader in Surface Guided Radiation Therapy (SGRT), have announced an expansion of their global strategic partnership.

This new agreement will see Vision RT provide GenesisCare with 30 new AlignRT systems, with potential for an additional 10, over the course of the next 2-3 years. Patients in GenesisCare centers in Australia, US, UK, and Spain are set to benefit from this agreement, with the first orders under this new contract currently being shipped. Once fully installed, this will expand the fleet of Vision RT systems within the GenesisCare network.

AlignRT offers a complete solution for high precision patient positioning throughout therapy to improve the accuracy of set-up and treatment. In traditional radiation therapy, cancer patients receive tattoos and other permanent marks to ensure treatment is delivered to a precise location. AlignRT uses 3D stereoscopic camera units and surface tracking to detect slight movements, automatically pausing treatment as needed, to safely deliver highly targeted tattoo-free radiation therapy. The technology is non-invasive and can be used for patients with any forms of cancer, including breast, brain, lung, liver, or head and neck cancer or sarcoma.

GenesisCare will expand its use of AlignRT technology by continuing to reach new patients with the help of Vision RT’s patient education website, The site supports the referring provider community through a patient education toolkit with marketing resources to educate and inform local providers and their patients.

“Vision RT and GenesisCare have been partnering for the past 3 years, and we have seen how AlignRT has significantly impacted the quality and efficiency of their radiotherapy treatments,” said Dr Norman Smith, CEO of Vision RT. “We are delighted that due to this success, the rollout within the GenesisCare network has been three times faster than expected. We’re thrilled that they have now decided to expand and deepen our partnership as AlignRT is standardised across their global fleet of linear accelerators.”

GenesisCare Global Chief Medical Officer Wally Curran, MD said: “GenesisCare’s expanded partnership with Vision RT will increase patient access across our network to the latest advances in SGRT. This will enable us to continue to provide the best possible life outcomes for our patients.

“The expansion of AlignRT systems across our global network will provide more patients with highly precise, tattoo-free radiation therapy and can minimize radiation exposure to the heart and other surrounding healthy tissue.”

Related articles

GenesisCare Enrolls First Patients to SpaceOAR Vue™ Hydrogel Global Clinical Trial

GenesisCare Appoints Seven Leading Oncologists to Chair its Global Research Committees

GenesisCare Repairing COVID Disrupted Pathways in Breast Cancer Care with First Sunnyvale Women’s Center

Eleven MJH Life Sciences™ Brands Announce Strategic Alliance Partnership (SAP) with GenesisCare